Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-01-28 to 2025-01-29
Current total value of award: $4822.86
Description: 4567075296!QUILLIVANT XR ORAL SUSP 60ML 5MG/ML